MARKET

DGX

DGX

Quest Diagnostics Inc
NYSE
145.59
+1.34
+0.93%
After Hours: 145.59 +0.01 +0.01% 16:15 07/26 EDT
OPEN
144.92
PREV CLOSE
144.25
HIGH
146.73
LOW
144.57
VOLUME
1.28M
TURNOVER
0
52 WEEK HIGH
150.59
52 WEEK LOW
116.97
MARKET CAP
16.21B
P/E (TTM)
19.64
1D
5D
1M
3M
1Y
5Y
1D
Integer Holdings (ITGR) Q2 Earnings Top Estimates, Margins Up
NASDAQ · 9h ago
DexCom's (DXCM) Q2 Earnings Beat Estimates, Revenues Miss
NASDAQ · 9h ago
Hologic (HOLX) Buys Endomag to Boost Breast Cancer Solutions
NASDAQ · 10h ago
Amedisys (AMED) Q2 Earnings Top Estimates, Gross Margin Down
NASDAQ · 14h ago
Maintaining Neutral Hold on Quest Diagnostics Amid Modest Growth and Pending Strategic Insights
Leerink Partners analyst Michael Cherny has reiterated their neutral stance on DGX stock, giving a Hold rating on July 24. Quest Diagnostics met the anticipated beat-and-raise scenario for the second quarter of 2024. The growth in organic requisition volume was marginally below expectations.
TipRanks · 20h ago
Terumo (TRUMY) Unit Reveals WEB 17 Device Effective in Aneurysms
NASDAQ · 1d ago
Molina Healthcare (MOH) Q2 Earnings Beat on Growing Membership
NASDAQ · 1d ago
Edwards Lifesciences (EW) Q2 Earnings Meet Mark, Margins Crash
NASDAQ · 1d ago
More
About DGX
Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company provides diagnostic insights from the results of its laboratory testing to enable people, physicians, and organizations to take action to improve health outcomes. It operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer channels: physicians, hospitals, and patients and consumers. It offers broad access to clinical testing through a nationwide network of laboratories, patient service centers, phlebotomists in physician offices, and connectivity resources, including call centers and mobile phlebotomists, nurses and other health and wellness professionals. The Company also focuses on artificial intelligence (AI) and digital pathology solutions for biopharmaceutical companies and pathology laboratories. It has implemented AI, digital and automation technologies across several laboratory and business functions.

Webull offers Quest Diagnostics Inc stock information, including NYSE: DGX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DGX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DGX stock methods without spending real money on the virtual paper trading platform.